16.98

2.86% -0.50

Fulgent Genetics Inc (FLGT)

Overview News Price History Option Chain Financials Discussions Forecast

Fulgent Genetics Inc stock is traded at $16.98, with a volume of 563.03K. It is down -2.86% in the last 24 hours and up +0.71% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Previous Close:

$17.48

Open:

$17.48

24h Volume:

563.03K

Relative Volume:

1.88

Market Cap:

$523.48M

Revenue:

$290.71M

Net Income/Loss:

$-163.43M

P/E Ratio:

-3.0985

EPS:

-5.48

Net Cash Flow:

$11.70M

1W Performance:

-5.14%

1M Performance:

+0.71%

6M Performance:

-24.03%

1Y Performance:

-26.33%

1-Day Range:

$16.75

$17.49

1-Week Range:

$16.66

$19.35

52-Week Range:

$14.76

$25.11

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name

Fulgent Genetics Inc

Sector

Healthcare (1169)

Industry

Diagnostics & Research (61)

Phone

626-350-0537

Address

4399 SANTA ANITA AVE, EL MONTE

Employee

1,313

Twitter

@FulgentGenetics

Next Earnings Date

2024-11-08

Latest SEC Filings

FLGT's Discussions on Twitter

Compare FLGT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FLGT Fulgent Genetics Inc	16.98	523.48M	290.71M	-163.43M	11.70M	-5.48
TMO Thermo Fisher Scientific Inc	508.90	191.99B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	204.09	145.87B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	117.33	33.47B	6.53B	1.26B	1.31B	4.35
IDXX Idexx Laboratories Inc	406.29	33.04B	3.90B	887.87M	798.08M	10.67
IQV Iqvia Holdings Inc	181.43	31.99B	15.41B	1.37B	2.11B	7.50

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-07-23	Initiated	UBS	Neutral
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Nov-18-22	Initiated	Raymond James	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Feb-04-22	Resumed	Piper Sandler	Overweight
Aug-05-21	Resumed	Credit Suisse	Underperform
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform
May-29-20	Initiated	BTIG Research	Buy
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

View All

Fulgent Genetics Inc Stock (FLGT) Latest News

Mar 13, 2025

Proficio Capital Partners LLC Invests $411,000 in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 13, 2025

Mar 12, 2025

AlphaQuest LLC Acquires 27,085 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 12, 2025

Fulgent Genetics (NASDAQ:FLGT) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Mar 12, 2025

Mar 11, 2025

Proficio Capital Partners LLC Purchases New Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Mar 11, 2025

Mar 10, 2025

Fulgent Genetics (NASDAQ:FLGT) Shares Gap Up on Insider Buying Activity - MarketBeat

Mar 10, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Update - MarketBeat

Mar 10, 2025

Mar 09, 2025

Fulgent Genetics (NASDAQ:FLGT) Upgraded to Hold at StockNews.com - MarketBeat

Mar 09, 2025

Mar 08, 2025

Piper Sandler Issues Pessimistic Forecast for Fulgent Genetics (NASDAQ:FLGT) Stock Price - MarketBeat

Mar 08, 2025

Mar 07, 2025

Fulgent Genetics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Fulgent Genetics Chief Financial Officer Acquires 40% More Stock - Simply Wall St

Mar 07, 2025

Mar 06, 2025

Insider Buying: Fulgent Genetics, Inc. (NASDAQ:FLGT) CFO Buys 100,000 Shares of Stock - MarketBeat

Mar 06, 2025

Mar 05, 2025

Fulgent Genetics CFO Makes a Major Stock Purchase! - TipRanks

Mar 05, 2025

Insider Buying: Paul Kim Acquires 100,000 Shares of Fulgent Gene - GuruFocus.com

Mar 05, 2025

Fulgent Genetics CFO Paul Kim purchases $1.6 million in company stock - Investing.com Australia

Mar 05, 2025

Fulgent Genetics (NASDAQ:FLGT) Given New $16.00 Price Target at Piper Sandler - Defense World

Mar 05, 2025

Fulgent Genetics (NASDAQ:FLGT) Releases FY 2025 Earnings Guidance - MarketBeat

Mar 05, 2025

Mar 04, 2025

Fulgent Genetics (NASDAQ:FLGT) Issues FY25 Earnings Guidance - MarketBeat

Mar 04, 2025

Mar 03, 2025

UBS Adjusts Fulgent Genetics Price Target to $20 From $27, Maintains Neutral Rating -March 03, 2025 at 11:20 am EST - Marketscreener.com

Mar 03, 2025

Mar 01, 2025

Fulgent Genetics Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Mar 01, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 01, 2025

Feb 28, 2025

Fulgent Genetics Reports 2024 Financial Results - TipRanks

Feb 28, 2025

Fulgent Genetics Revenue Tops Estimates - MSN

Feb 28, 2025

Fulgent Genetics earnings beat by $0.43, revenue topped estimates - Investing.com Canada

Feb 28, 2025

Earnings call transcript: Fulgent Genetics Q4 2024 beats EPS forecast By Investing.com - Investing.com South Africa

Feb 28, 2025

Fulgent Genetics Revenue Tops Estimates - The Motley Fool

Feb 28, 2025

Earnings call transcript: Fulgent Genetics Q4 2024 beats EPS forecast - Investing.com

Feb 28, 2025

Fulgent Genetics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 28, 2025